Summary
The BESPOKE CRC study will prospectively enroll patients who have undergone surgery for stage
I to IV colorectal cancer (CRC) and who have residual formalin-fixed paraffin-embedded (FFPE)
tissue available will provide FFPE and whole blood samples. Patients will receive SIGNATERA™
test results and may be recommended for post-operative systemic therapy or observation by
their treating clinician. Patients will be followed for up to two years with periodic whole
blood collection. The study also has a control arm that will consist of matched Stage I to IV
CRC cases that have a minimum of least 2 years clinical follow-up data.
Treatment Sites in Georgia
John B Amos Cancer Center
1831 Fifth Avenue
Columbus, GA 31904
706-780-6201
Northeast Georgia Medical Center - GainesvilleNGMC-Gainesville
Wisteria Building Suite 420
200 South Enota
Gainesville, GA 30501
770-219-8822
www.nghs.com
Pearlman Cancer Center at South Georgia Medical Center2501 North Patterson Street
Valdosta, GA 31602
229-259-4628
www.sgmc.org
Phoebe Cancer Center at Phoebe Putney Memorial Hospital425 Third Avenue
Albany, GA 31702
(229) 312-0406
www.phoebehealth.com